{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:36Z","timestamp":1793301156142,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jpsychires.2020.02.026","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T02:42:54Z","timestamp":1582771374000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Clozapine in bipolar disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"125","author":[{"given":"Andre","family":"Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Velosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar M.","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiane","family":"de Azevedo Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpsychires.2020.02.026_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004850-199703000-00006","article-title":"Response to clozapine in acute mania is more rapid than that of chlorpromazine","volume":"12","author":"Barbini","year":"1997","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"14","key":"10.1016\/j.jpsychires.2020.02.026_bib2","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1017\/S0033291714000439","article-title":"Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications","volume":"44","author":"Burdick","year":"2014","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.jpsychires.2020.02.026_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1176\/ajp.153.6.759","article-title":"Clozapine for treatment-refractory mania","volume":"153","author":"Calabrese","year":"1996","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2020.02.026_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4088\/JCP.v67n0318","article-title":"The effects of long-term clozapine add-on therapy on the rehospitalization rate and the mood polarity patterns in bipolar disorders","volume":"67","author":"Chang","year":"2006","journal-title":"J. Clin. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2020.02.026_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0957154X07070335","article-title":"The history of clozapine and its emergence in the US market: a review and analysis","volume":"18","author":"Crilly","year":"2007","journal-title":"Hist. Psychiatr."},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2020.02.026_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-0327(97)00160-2","article-title":"Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics","volume":"48","author":"Frye","year":"1998","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2020.02.026_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1017\/S0033291712001614","article-title":"Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression?","volume":"43","author":"Gildengers","year":"2013","journal-title":"Psychol. Med"},{"issue":"11","key":"10.1016\/j.jpsychires.2020.02.026_bib8","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1176\/ajp.152.11.1635","article-title":"Relapse and impairment in bipolar disorder","volume":"152","author":"Gitlin","year":"1995","journal-title":"Am. J. Psychiatr"},{"issue":"Suppl 3","key":"10.1016\/j.jpsychires.2020.02.026_bib9","first-page":"8","article-title":"Clozapine reduces violence and persistent aggression in schizophrenia","volume":"59","author":"Glazer","year":"1998","journal-title":"J. Clin. Psychiatr"},{"issue":"2","key":"10.1016\/j.jpsychires.2020.02.026_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1590\/1516-4446-2014-1554","article-title":"Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice","volume":"37","author":"Goi","year":"2015","journal-title":"Braz. J. Psychiatr"},{"issue":"10027","key":"10.1016\/j.jpsychires.2020.02.026_bib11","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jpsychires.2020.02.026_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4088\/JCP.v61n0907","article-title":"A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder","volume":"61","author":"Guille","year":"2000","journal-title":"J. Clin. Psychiatr"},{"issue":"10","key":"10.1016\/j.jpsychires.2020.02.026_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0006-3223(93)90043-D","article-title":"Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine","volume":"34","author":"Hagger","year":"1993","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.jpsychires.2020.02.026_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/NDT.S122367","article-title":"Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study","volume":"13","author":"Ifteni","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat"},{"issue":"1","key":"10.1016\/j.jpsychires.2020.02.026_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine: a clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann. Clin. Psychiatr."},{"issue":"Suppl 9","key":"10.1016\/j.jpsychires.2020.02.026_bib16","first-page":"35","article-title":"Treatment-resistant schizophrenic patients","volume":"57","author":"Kane","year":"1996","journal-title":"J. Clin. Psychiatr"},{"issue":"8","key":"10.1016\/j.jpsychires.2020.02.026_bib17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4088\/JCP.09com05497yel","article-title":"Clozapine: more side effects but still the best antipsychotic","volume":"71","author":"Kang","year":"2010","journal-title":"J. Clin. Psychiatr"},{"issue":"2","key":"10.1016\/j.jpsychires.2020.02.026_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/0253-7613.153434","article-title":"Gamma activity model for treatment-resistant bipolar psychotic mania","volume":"47","author":"Kumar","year":"2015","journal-title":"Indian J. Pharmacol"},{"issue":"9896","key":"10.1016\/j.jpsychires.2020.02.026_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.02.026_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bdi.12272","article-title":"Clozapine for treatment-resistant bipolar disorder: a systematic review","volume":"17","author":"Li","year":"2015","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jpsychires.2020.02.026_bib21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2018.12.044","article-title":"Identifying cognitive subgroups in bipolar disorder: A cluster analysis","volume":"246","author":"Lima","year":"2019","journal-title":"J. Affect. Disord"},{"issue":"6","key":"10.1016\/j.jpsychires.2020.02.026_bib22","first-page":"337","article-title":"Risperidone or clozapine combined with lithium in treatment of acute mania","volume":"11","author":"Liu","year":"2001","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.02.026_bib23","article-title":"Progression of the functional deficit in a group of patients with bipolar disorder: a cluster analysis based on longitudinal data","author":"L\u00f3pez-Villarreal","year":"2019","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci"},{"issue":"10","key":"10.1016\/j.jpsychires.2020.02.026_bib24","first-page":"411","article-title":"Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia","volume":"52","author":"McElroy","year":"1991","journal-title":"J. Clin. Psychiatr"},{"issue":"1","key":"10.1016\/j.jpsychires.2020.02.026_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatr"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.02.026_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: balancing safety with superior antipsychotic efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.02.026_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.02.026_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s13311-017-0552-9","article-title":"Clozapine as a Model for Antipsychotic Development","volume":"14","author":"Nucifora","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.jpsychires.2020.02.026_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.12581","article-title":"Areas of controversy in neuroprogression in bipolar disorder","volume":"134","author":"Passos","year":"2016","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"10.1016\/j.jpsychires.2020.02.026_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.02.026_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0006-3223(92)90108-C","article-title":"Clozapine in the treatment of dysphoric mania","volume":"32","author":"Suppes","year":"1992","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2020.02.026_bib34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania","volume":"156","author":"Suppes","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2020.02.026_bib30","first-page":"13","article-title":"Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: an overview of evidence","volume":"22","author":"Tamsyn","year":"2019","journal-title":"Bipolar Disord."},{"issue":"5","key":"10.1016\/j.jpsychires.2020.02.026_bib35","first-page":"291","article-title":"Randomized controlled trial comparing quetiapine with lithium and clozapine with lithium in the treatment of female patients with mania","volume":"23","author":"Tang","year":"2011","journal-title":"Shanghai Arch Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2020.02.026_bib36","first-page":"347","article-title":"A study of olanzapine versus clozapine in the treatment of mania","volume":"12","author":"Wei","year":"2002","journal-title":"J. Clin. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2020.02.026_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"issue":"11","key":"10.1016\/j.jpsychires.2020.02.026_bib38","first-page":"877","article-title":"Clinical controlled study on quetiapine and clozapine combined with lithium in patients with mania","volume":"42","author":"Ying","year":"2007","journal-title":"Chin. Pharmaceut. J."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619312579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619312579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:13:42Z","timestamp":1758366822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395619312579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":37,"alternative-id":["S0022395619312579"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.02.026","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine in bipolar disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}